Preliminary Single-Center Experience of Bromelain-Based Eschar Removal in Children with Mixed Deep Dermal and Full Thickness Burns
- PMID: 36013039
- PMCID: PMC9410402
- DOI: 10.3390/jcm11164800
Preliminary Single-Center Experience of Bromelain-Based Eschar Removal in Children with Mixed Deep Dermal and Full Thickness Burns
Abstract
Introduction: Early eschar removal is the standard management of burns. The goal is to remove all of the necrotic tissue and render the wound suitable for healing or skin grafting. The enzymatic debridement of burn wounds allows for minimally invasive removal of burn eschar. The aim of the study was to describe and compare the demographic characteristics, surgical treatment and outcomes of patients treated with Nexobrid® with patients who had standard surgical excision.
Material and methods: A retrospective review was conducted on children who underwent enzymatic debridement. The study group was compared with children treated with the standard of care (SoC).
Results: Twelve children (mean age 8 years, range 3 to 15 years) with mixed deep dermal and full thickness burn wounds were treated with Nexobrid®. The mean size of the burns was 29% TBSA. The median percentage TBSA debrided using Nexobrid® was 15% (range 2-27%). In a clinical assessment, enzymatic debridement was effective in removing dead tissue in a single application. No adverse reaction to Nexobrid® and serious complications after enzymatic procedure were recorded in the study group. The estimated relative risk of the need for reconstructive procedures decreases 3.5 times for the study group (RR 3.5, 95%CI 0.9-13.5, p = 0.089).
Conclusion: The bromelain-based enzymatic method offers a good and safe debridement option to improve the treatment and life quality of children with severe burns. The main outcome of interest was the number of reconstructive procedures due to scar contractures, which was reduced in the group treated enzymatically compared to the SoC-treated children.
Keywords: burns; enzymatic debridement; wound healing.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: An European consensus.Burns. 2017 Dec;43(8):1640-1653. doi: 10.1016/j.burns.2017.07.025. Epub 2017 Oct 13. Burns. 2017. PMID: 29033046
-
A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.Isr Med Assoc J. 2020 Feb;22(2):83-88. Isr Med Assoc J. 2020. PMID: 32043324
-
Accelerated wound healing of enzymatically debrided deep dermal burn wounds after the use of fish skin (Kerecis Omega3 Wound®) in comparison to Suprathel®.Burns. 2025 Jun;51(5):107471. doi: 10.1016/j.burns.2025.107471. Epub 2025 Mar 28. Burns. 2025. PMID: 40318593
-
Enzymatic debridement: past, present, and future.Acta Chir Belg. 2022 Aug;122(4):279-295. doi: 10.1080/00015458.2022.2068746. Epub 2022 May 4. Acta Chir Belg. 2022. PMID: 35440290 Review.
-
Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.Burns. 2020 Jun;46(4):782-796. doi: 10.1016/j.burns.2020.03.002. Epub 2020 Mar 30. Burns. 2020. PMID: 32241591
Cited by
-
An Overview of Recent Developments in the Management of Burn Injuries.Int J Mol Sci. 2023 Nov 15;24(22):16357. doi: 10.3390/ijms242216357. Int J Mol Sci. 2023. PMID: 38003548 Free PMC article. Review.
-
The Effectiveness of an Alloplastic Epidermal Substitute in the Treatment of Burn Wounds in Children: A Comparative Clinical Study of Skin Substitutes and Silver and Paraffin Gauze Dressings.J Clin Med. 2024 Nov 28;13(23):7238. doi: 10.3390/jcm13237238. J Clin Med. 2024. PMID: 39685697 Free PMC article.
-
Metabolic and Hormonal Changes in Pediatric Burn Patients: Mechanisms, Evidence, and Care Strategies.Eur Burn J. 2025 Apr 7;6(2):17. doi: 10.3390/ebj6020017. Eur Burn J. 2025. PMID: 40265372 Free PMC article. Review.
-
Alloplastic Epidermal Skin Substitute in the Treatment of Burns.Life (Basel). 2023 Dec 27;14(1):43. doi: 10.3390/life14010043. Life (Basel). 2023. PMID: 38255658 Free PMC article. Review.
-
Comparative Clinical Study of Suprathel® and Jelonet® Wound Dressings in Burn Wound Healing after Enzymatic Debridement.Biomedicines. 2023 Sep 22;11(10):2593. doi: 10.3390/biomedicines11102593. Biomedicines. 2023. PMID: 37892967 Free PMC article.
References
-
- Pruitt B.A., Jr., McManus A.T., Kim S.H., Goodwin C.W. Burn wound infections: Current status. World J. Surg. 1998;22:135–145. - PubMed
-
- Tompkins R.G., Remensnyder J.P., Burke J.F., Tompkins D.M., Hilton J.F., Schoenfeld D.A., Behringer G.E., Bondoc C.C., Briggs S.E., Quinby W.C., Jr. Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann. Surg. 1988;208:577–585. doi: 10.1097/00000658-198811000-00006. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources